Lufax Holding Ltd vs 22nd Century Group Inc — how do they compare? Lufax Holding Ltd trades at $0.99 (market cap $982.89M), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Lufax Holding Ltd is far larger — about 1581× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 3,323,384). Which is the better fit depends on your goals — on Pluang, investors hold Lufax Holding Ltd for 13 Days and 22nd Century Group Inc for 32 Days on average.
| LU | XXII | |
|---|---|---|
Market Cap | $982.89M | $621.67K |
Volume | 3,323,384 | 45,625 |
Sector | Financials | Consumer Staples |
52-Week High | $3.93 | $483.00 |
52-Week Low | $0.95 | $0.80 |
Typical Hold Time | 13 Days | 32 Days |
Enterprise Value | $58.81B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Lufax (LU) trades at $0.986, up 0.47% on the day, but shows significant fundamental challenges with consecutive quarterly losses and declining revenue. The company recently completed a 10:1 reverse stock split and faces bearish technical signals despite some oversold RSI readings. Analyst sentiment remains predominantly bullish with 69% buy ratings, pointing to potential value in the depressed valuation multiples.
The investment case hinges on Lufax's deep value proposition trading at 0.07x book value, but requires successful navigation of regulatory headwinds and return to profitability. Key risks include persistent net losses, Chinese regulatory uncertainty, and declining top-line performance that could pressure the stock further despite strong institutional backing from parent company Ping An.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →